Seville, 6 March 2024

‍

ABCDx is collaborating with Andalusian hospitals to improve stroke triage inside ambulances. Thanks to a public-private grant from the Junta de Andalucía (PIP-0009-2021) the Hospital Universitario Virgen Macarena/IBIS is leading a study to evaluate the potential use of a rapid Point-of-Care device for the direct transfer of stroke patients with a large vessel occlusion (LVO) from the ambulance to the thrombectomy centers. The test works by measuring two biomarkers in blood and reading the results by an APP. 

Currently, the follow-up period of the patients is ongoing, and the final results are estimated to be reached by the beginning of May.

After this study, it is expected that this tool will be easily used at the ambulances, and it will differentiate stroke patients with an LVO allowing their direct transfer to the thrombectomy centers.

ABCDx is improving the tool to make it even faster (10 minutes) and simpler (one drop of blood) having more biomarkers in the device (FABP/NTproBNP and d-dimer).

This type of collaboration sis important to approach to the patient results of innovative technology developed at public centers through research that is protected and then licensed to biotech startups.

Andalusian Hospitals

Innovation in the public hospital network of Andalusia is managed by La Fundación Progreso y Salud.

More information available here.

ABCDx

Based in Geneva and Barcelona, ABCDx is at the forefront of developing diagnostic solutions for brain injuries. The company is dedicated to the advancement of medical technology, striving to improve diagnostics and treatment outcomes for stroke and other brain injuries worldwide. 

Contact Information 

For more information about ‘LVOcheck’ please contact Jean-Charles Sanchez at jean-charles.sanchez@abcdx.ch  

‍